U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT06904482) titled 'Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood' on March 31.
Brief Summary: The purpose of this study is to see if see if adding the specific combination of donors can result in acceptable levels of survival without evidence of disease.
Study Start Date: April 01
Study Type: INTERVENTIONAL
Condition:
aGVHD
Acute Myelogenous Leukemia
Acute Lymphocytic Leukemia
Myelodysplastic Syndromes
Intervention:
BIOLOGICAL: Haplo-Identical / Cord Blood Transplant
Cord Blood Unit Selection Cord Blood Unit Selection should be consistent with published guidelines5 with the understanding that the goal cell dose is 1x105 C...